Adults 18 to 64, any sex, with Tobacco Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Amount of Tobacco Product UsedPrimary· 6 weeks
Total number of cigarettes smoked and puffs of e-cigarettes used
Cigarettes smoked per day
Group
Value
95% CI
Menthol Ban Only for Cigarettes
13.1
± 5.5
Menthol Ban for Cigarettes and E-cigarettes
18.6
± 5.7
No Menthol Ban
15.3
± 5.0
Puffs of e-cigarettes used per day
Group
Value
95% CI
Menthol Ban Only for Cigarettes
56.7
± 180.2
Menthol Ban for Cigarettes and E-cigarettes
10.7
± 24.9
No Menthol Ban
4.5
± 8.6
How Much of Each Product is Obtained From the "Experimental Marketplace"Secondary· 6 weeks
Number of packs of cigarettes obtained and amount of e-liquid obtained from the "experimental marketplace"
Packs of cigarettes
Group
Value
95% CI
Menthol Ban Only for Cigarettes
22.6
± 10.38
Menthol Ban for Cigarettes and E-cigarettes
29.3
± 11.06
No Menthol Ban
28.8
± 10.7
Units of e-cigarette liquid
Group
Value
95% CI
Menthol Ban Only for Cigarettes
3.13
± 3.16
Menthol Ban for Cigarettes and E-cigarettes
1.2
± 1.57
No Menthol Ban
1.06
± 1.34
Motivation to Quit Smoking CigarettesSecondary· 6 weeks
Based on a question asking how motivated from 1 (not at all) to 10 (extremely) the participant is to quit smoking cigarettes at this time
Group
Value
95% CI
Menthol Ban Only for Cigarettes
3.6
± 2.2
Menthol Ban for Cigarettes and E-cigarettes
3.1
± 2.2
No Menthol Ban
3.2
± 1.7
Adverse events — posted to ClinicalTrials.gov
Time frame: For the duration of each participant's participation (up to 6 weeks for each participant).
Reporting threshold: 5%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
In this pilot study, menthol cigarette smokers will be randomized to one of three experimental marketplaces: 1) a condition simulating a ban on menthol cigarettes but not menthol e-cigarettes (condition A); 2) a condition simulating a ban on both menthol cigarettes and menthol e-cigarettes (Condition B); and 3) a condition in which menthol is not banned for either product (Condition C - the control condition). All conditions would have medicinal nicotine available if subjects decide to quit tobacco products entirely. At visits occurring every two weeks over a 6 week period, subjects will receive "credits" that they could exchange for any product available in their randomized marketplace condition. Outcomes include the amount of each tobacco product used.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 10 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03402243.